Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.

Oncologist · 2023 · PMC9847538 · PMID 36200844

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

2 , there was a clear trend of increased use of NAC over the study period, with proportion of patients receiving NAC increased from 12.3% of all patients in 2010 to 28.3% in 2015 in all programs.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.